Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: September 5, 2025
Reporting Period: Event-based (September 5, 2025)
Context: The filing discloses the preparation of presentation materials intended for use at the H.C. Wainwright 27th Annual Global Investment Conference (September 8–10, 2025). The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of forward-looking presentation materials rather than a financial results announcement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely addresses the dissemination of presentation materials under Regulation FD.
Guidance, Outlook, and Risks
- Management Commentary: Management intends to use the attached presentation materials (Exhibit 99.1) to discuss operations and performance at an upcoming investor conference.
- Legal Status of Information: The information contained in Item 7.01 and Exhibit 99.1 is furnished, not "filed," under the Exchange Act. It is not subject to Section 18 liabilities and shall not be incorporated by reference into other filings.
- Outlook: No specific financial guidance or numerical outlook is provided in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation Materials) for specific operational updates and financial projections, as the 8-K text itself contains no data.
- Verify the company's status as an emerging growth company and its implications for financial reporting standards.
- Confirm the dates of the H.C. Wainwright 27th Annual Global Investment Conference (September 8–10, 2025) to access the live presentation.
- Note that the furnished information is not incorporated by reference into future SEC filings.